Sino Biopharm Invests in Sinovac LS, A Leading COVID-19 Vaccine Company in China
Sino Biopharm Invests in Sinovac LS, A Leading COVID-19 Vaccine Company in China

HONG KONG, Dec 7, 2020 – (ACN Newswire) – Sino Biopharmaceutical Limited (“Sino Biopharm” or the “Group”; HKEX: 1177) has announced the investment of US$515 million in Sinovac Life Sciences Co., Ltd. (“Sinovac LS”, previously known as Sinovac Research and Development Co., Ltd.), which will be funded by internal resources of the Group and result... » read more

Sino Biopharmaceutical Announces 2020 Third Quarterly Results
Sino Biopharmaceutical Announces 2020 Third Quarterly Results

HONG KONG, Nov 30, 2020 – (ACN Newswire) – Sino Biopharmaceutical Limited (“Sino Biopharmaceutical” or the “Company”, together with its subsidiaries, the “Group”) (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited third quarterly results for the nine months ended 30 September 2020 (the “review period”). During the review period,... » read more

Nissin Foods Announces 2020 Q3 Financial Results
Nissin Foods Announces 2020 Q3 Financial Results

HONG KONG, Nov 6, 2020 – (ACN Newswire) – Nissin Foods Company Limited (“Nissin Foods” or the “Company”, and together with its subsidiaries, the “Group”; Stock code: 1475) has today announced its 2020 financial information for the nine months ended 30 September 2020 (“the reporting period”). Revenue of the Group amounted to HK$2,685.6 million, representing... » read more